Galecto, Inc. /
Damora Therapeutics, Inc.
Galecto, Inc. completes purchase of Damora Therapeutics, Inc.




Source for the buyer and target: Galecto, Inc.
For the buyer and target.
“On November 10, 2025, Galecto, Inc., a Delaware corporation (the “Company” or “Galecto”), acquired Damora Therapeutics, Inc., a Delaware corporation (“Damora”), in accordance with the terms of the Agreement and Plan of Merger, dated November 10, 2025 (the “Merger Agreement”), by and among the Company, Daylight Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“First Merger Sub”), Daylight Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Second Merger Sub”), and Damora.”
Published 10 Nov 2025
Open the sourceWhat happened
Galecto, Inc. completed its acquisition of Damora Therapeutics, Inc., according to a filing dated Nov. 10, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Galecto, Inc. completes purchase of Damora Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Galecto, Inc. completes purchase of Damora Therapeutics, Inc. Galecto, Inc. completed its acquisition of Damora Therapeutics, Inc., according to a filing dated Nov. 10, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly